Key Metrics
CiteScore 

5.7
H-Index 

75
Impact Factor 

< 5
SJR 

Q2Immunology

SNIP 

0.93
Recommended pre-submission checks
Powered by 

Topics Covered on Microbial Drug Resistance
Microbial Drug Resistance Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Microbial Drug Resistance ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Microbial Drug Resistance
Emergence of Teicoplanin and Linezolid Resistance in Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus.
- 1 Jun 2026
- Microbial drug resistance (Larchmont, N.Y.)
A Multicenter Surveillance of Antimicrobial Resistance Among Pseudomonas aeruginosa in Hospitals of the Greater Accra Region of Ghana.
- 1 Jun 2026
- Microbial drug resistance (Larchmont, N.Y.)
Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials.
- 13 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Persistence of MCR-1-Positive Colistin-Resistant E. coli ST162, ST93, and ST3941 Clones in Poultry Farms, Algeria.
- 12 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Community Fecal Samples in Sivas, Türkiye: Detection of the ST131 Clone.
- 8 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Clinical Outcomes of High-Dose Ampicillin-Sulbactam Combined with Colistin in the Treatment of Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii.
- 8 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Emergence of Teicoplanin and Linezolid Resistance in Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus.
- 1 Jun 2026
- Microbial drug resistance (Larchmont, N.Y.)
A Multicenter Surveillance of Antimicrobial Resistance Among Pseudomonas aeruginosa in Hospitals of the Greater Accra Region of Ghana.
- 1 Jun 2026
- Microbial drug resistance (Larchmont, N.Y.)
Early Transition to Oral Levonadifloxacin in Two Divergent Staphylococcal Infections: Integrating Features of Levonadifloxacin and Evidence from POET and OVIVA Trials.
- 13 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Persistence of MCR-1-Positive Colistin-Resistant E. coli ST162, ST93, and ST3941 Clones in Poultry Farms, Algeria.
- 12 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli from Community Fecal Samples in Sivas, Türkiye: Detection of the ST131 Clone.
- 8 May 2026
- Microbial drug resistance (Larchmont, N.Y.)
Clinical Outcomes of High-Dose Ampicillin-Sulbactam Combined with Colistin in the Treatment of Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii.
- 8 May 2026
- Microbial drug resistance (Larchmont, N.Y.)